Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Rheumatoid Arthritis

Free Subscription Articles published in Clin Exp Immunol Retrieve available abstracts of 30 articles: HTML format

Single Articles

July 2023
1. MORALES-NUNEZ JJ, Munoz-Valle JF, Garcia-Chagollan M, Cerpa Cruz S, et al
   Aberrant B cell activation and B cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.
   Clin Exp Immunol. 2023 Jul 19:uxad076. doi: 10.1093.
   PubMed     Abstract available
   
   
   
2. SUN HG, Jiang Q, Fan WJ, Shen XY, et al
   TAGAP Activates Th17 Cell Differentiation by Promoting RhoA and NLRP3 to Accelerate Rheumatoid Arthritis Development.
   Clin Exp Immunol. 2023 Jul 17:uxad084. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2023
3. ZHOU L, Wang H, Zhang H, Wang F, et al
   Diagnostic markers and potential therapeutic agents for Sjogren's syndrome screened through multiple machine learning and molecular docking.
   Clin Exp Immunol. 2023;212:224-238.
   PubMed     Abstract available
   
   
   
4. HASHIMOTO T, Yoshida K, Yokoyama Y, Hashimoto N, et al
   Tocilizumab suppresses NF-kappa B activation via toll-like receptor 9 signaling by reducing cell-free DNA in rheumatoid arthritis.
   Clin Exp Immunol. 2023 Jun 4:uxad064. doi: 10.1093.
   PubMed     Abstract available
   
   
   May 2023
5. WU XN, Gao ZW, Yang L, Zhang J, et al
   CD5L aggravates rheumatoid arthritis progression via promoting synovial fibroblasts proliferation and activity.
   Clin Exp Immunol. 2023 May 16:uxad054. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2023
6. RIVIERE E, Chivasso C, Pascaud J, Bechara R, et al
   Hyperosmolar environment and salivary gland epithelial cells increase extra-cellular matrix remodeling and lymphocytic infiltration in Sjogren's syndrome.
   Clin Exp Immunol. 2023;212:39-51.
   PubMed     Abstract available
   
   
   March 2023
7. LARAGIONE T, Harris C, Gulko PS
   Combination therapy of a TRPV2 agonist with a TNF inhibitor achieves sustained suppression of disease severity and reduced joint damage.
   Clin Exp Immunol. 2023;211:233-238.
   PubMed     Abstract available
   
   
   
8. CHO S, Jang E, Yoon T, Hwang H, et al
   A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.
   Clin Exp Immunol. 2023;211:31-45.
   PubMed     Abstract available
   
   
   January 2023
9. ZONG M, Cheng Y, Ye B, Chen S, et al
   Preparation of Mesoporous Silica Nanocarriers Targeting Glucose-6-Phosphate Isomerase Inhibition and Application in the Treatment of Rheumatoid Arthritis.
   Clin Exp Immunol. 2023 Jan 4:uxac116. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2022
10. WEYAND CM, Wu B, Huang T, Hu Z, et al
    Mitochondria as disease-relevant organelles in rheumatoid arthritis.
    Clin Exp Immunol. 2022 Nov 24:uxac107. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2022
11. VALLI A, Kuuliala K, Virtanen A, Kuuliala A, et al
    Tofacitinib treatment modulates the levels of several inflammation-related plasma proteins in rheumatoid arthritis and baseline levels of soluble biomarkers associate with the treatment response.
    Clin Exp Immunol. 2022 Sep 17. pii: 6702616. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2022
12. ZHENG L, Xu L, Hu F, Xue J, et al
    Elevated expression of TAM receptor tyrosine kinase in synovial fluid and synovial tissue of rheumatoid arthritis.
    Clin Exp Immunol. 2022 Aug 11. pii: 6661266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. WANG W, Xiang T, Yang Y, Wang Z, et al
    E3 Ubiquitin Ligases STUB1 Contributes to the Th17/Treg Imbalance via the Ubiquitination of Aryl Hydrocarbon Receptor in Rheumatoid Arthritis.
    Clin Exp Immunol. 2022 Aug 9. pii: 6659032. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2022
14. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
    The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
    Clin Exp Immunol. 2022;208:95-102.
    PubMed     Abstract available
    
    
    
15. RUSCITTI P, Berardicurti O, Di Cola I, Di Muzio C, et al
    The hyper-expression of NLRP4 characterizes the occurrence of macrophage activation syndrome assessing STING pathway in adult-onset Still's disease.
    Clin Exp Immunol. 2022;208:95-102.
    PubMed     Abstract available
    
    
    
16. XIE Y, Jiang X, Wang P, Zheng X, et al
    SR-A neutralizing antibody: potential drug candidate for ameliorating osteoclastogenesis in rheumatoid arthritis.
    Clin Exp Immunol. 2022;207:297-306.
    PubMed     Abstract available
    
    
    January 2022
17. QIAN S, Xu J, Zhao S, Yang P, et al
    CMTM6: increased circulating level and up-regulated expression in labial salivary glands in patients with primary Sjogren's syndrome.
    Clin Exp Immunol. 2022;207:65-71.
    PubMed     Abstract available
    
    
    December 2021
18. PATEL S, Ramnoruth N, Wehr P, Rossjohn J, et al
    Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T cell subpopulations in rheumatoid arthritis using flow-cytometry based peptide-MHC class-II tetramer staining.
    Clin Exp Immunol. 2021 Dec 5. pii: 6453380. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2021
19. OLSSON AM, Povoleri GAM, Somma D, Ridley ML, et al
    miR-155 overexpressing monocytes resemble HLA highISG15 + synovial tissue macrophages from patients with rheumatoid arthritis and induce polyfunctional CD4+ T cell activation.
    Clin Exp Immunol. 2021 Nov 30. pii: 6446881. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. HANLON MM, Canavan M, Barker BE, Fearon U, et al
    Metabolites as drivers and targets in Rheumatoid Arthritis.
    Clin Exp Immunol. 2021 Nov 27. pii: 6445033. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. SHIMOJIMA Y, Ichikawa T, Kishida D, Takamatsu R, et al
    Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
    Clin Exp Immunol. 2021;206:184-195.
    PubMed     Abstract available
    
    
    September 2021
22. TANG Y, Bai Z, Qi J, Lu Z, et al
    Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mTOR signaling pathway in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Sep 24. doi: 10.1111/cei.13663.
    PubMed     Abstract available
    
    
    August 2021
23. NOCTURNE G, Ly B, Paoletti A, Pascaud J, et al
    Long-term exposure to monoclonal anti-TNF is associated with an increased risk of lymphoma in BAFF-transgenic mice.
    Clin Exp Immunol. 2021;205:169-181.
    PubMed     Abstract available
    
    
    June 2021
24. ROOS LJUNGBERG K, Martinsson K, Wettero J, Svard A, et al
    Circulating anti-citrullinated protein antibodies containing secretory component are prognostic for arthritis onset in at-risk patients.
    Clin Exp Immunol. 2021;204:344-351.
    PubMed     Abstract available
    
    
    
25. TIAN J, Zhou D, Xiang L, Liu X, et al
    MiR-223-3p inhibits inflammation and pyroptosis in monosodium urate-induced rats and fibroblast-like synoviocytes by targeting NLRP3.
    Clin Exp Immunol. 2021;204:396-410.
    PubMed     Abstract available
    
    
    May 2021
26. YAMANE K, Nakamura H, Hamasaki M, Minei Y, et al
    Immune complexome analysis reveals the presence of immune complexes and identifies disease-specific immune complex antigens in saliva samples from patients with Sjogren's syndrome.
    Clin Exp Immunol. 2021;204:212-220.
    PubMed     Abstract available
    
    
    April 2021
27. ISAILOVIC N, Ceribelli A, Cincinelli G, Vecellio M, et al
    Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2021 Apr 26. doi: 10.1111/cei.13609.
    PubMed     Abstract available
    
    
    March 2021
28. OSADA A, Matsumoto I, Mikami N, Ohyama A, et al
    Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
    Clin Exp Immunol. 2021;203:385-399.
    PubMed     Abstract available
    
    
    
29. HALPERT G, Halperin Sheinfeld M, Monteran L, Sharif K, et al
    The tellurium-based immunomodulator, AS101 ameliorates adjuvant-induced arthritis in rats.
    Clin Exp Immunol. 2021;203:375-384.
    PubMed     Abstract available
    
    
    February 2021
30. GLENNON-ALTY L, Moots RJ, Edwards SW, Wright HL, et al
    Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression.
    Clin Exp Immunol. 2021;203:151-159.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: